What does DS - Medical do?

DS - Medical is a specialist medical practice in Stavelot. Private Limited, started on 19 March 2021, 4 establishments.

What is the address of DS - Medical?

The registered office of DS - Medical is located at Ster 10 box D, 4970 Stavelot.

Is DS - Medical still active?

Yes. According to the CBE (30 October 2026) DS - Medical is active, legal situation “Normale toestand”, started on 19 March 2021.

Is DS - Medical registered on Peppol?

Yes, DS - Medical is registered on the Peppol network with ID 0208:0765435017.

What is the enterprise number of DS - Medical?

The enterprise number of DS - Medical is BE0765435017.

When was DS - Medical founded?

DS - Medical was founded on 19 March 2021.

Who are the directors of DS - Medical?

According to the 2025 annual accounts, the directors of DS - Medical are: Damien SKA.

Is DS - Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 March 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 4 establishments in the CBE.

How much profit did DS - Medical make in 2025?

DS - Medical posted a profit after taxes of € 308,066 in financial year 2025.

What is the revenue of DS - Medical?

As a small company, DS - Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 761,044.

How many employees does DS - Medical have?

According to the 2025 annual accounts, DS - Medical has 0.6 full-time equivalents (FTE).

DS - Medical (Private Limited) - Stavelot - BE0765435017

Dossier DS - Medical, printed on 30 October 2026 from databakkes.be/en/0765435017/ds-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DS - Medical from Stavelot, company number BE0765435017, closed financial year 2025 with a result of € 308,066 after tax. For that financial year DS - Medical recorded a gross margin of € 761,044 and equity of € 531,433. Compared with financial year 2024, the result moved from € 284,995 to € 308,066. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Healthy

€ 531,433

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 308,066

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 100,447

▼ 88% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 308,066 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 65,695

▲ 238% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 38,004

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 74,734

▼ 60% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 23,991

▲ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,964

▲ 219% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 620,219 Gross margin 2022: € 620,219 First fiscal year in the series	€ 697,439 Gross margin 2023: € 697,439 ▲ 12% vs 2022 (€ 620,219) Favourable step	€ 684,189 Gross margin 2024: € 684,189 ▼ 2% vs 2023 (€ 697,439) Unfavourable step	€ 761,044 Gross margin 2025: € 761,044 ▲ 11% vs 2024 (€ 684,189) Favourable step	▲ 11%
Profit after taxes	€ 302,365 Profit after taxes 2022: € 302,365 First fiscal year in the series	€ 275,209 Profit after taxes 2023: € 275,209 ▼ 9% vs 2022 (€ 302,365) Unfavourable step	€ 284,995 Profit after taxes 2024: € 284,995 ▲ 4% vs 2023 (€ 275,209) Favourable step	€ 308,066 Profit after taxes 2025: € 308,066 ▲ 8% vs 2024 (€ 284,995) Favourable step	▲ 8%
Equity	€ 531,433 Equity 2022: € 531,433 First fiscal year in the series	€ 805,842 Equity 2023: € 805,842 ▲ 52% vs 2022 (€ 531,433) Favourable step	€ 531,433 Equity 2024: € 531,433 ▼ 34% vs 2023 (€ 805,842) Unfavourable step	€ 531,433 Equity 2025: € 531,433 Unchanged (€ 531,433) Unchanged
Total debts	€ 852,682 Total debts 2022: € 852,682 First fiscal year in the series	€ 422,804 Total debts 2023: € 422,804 ▼ 50% vs 2022 (€ 852,682) Favourable step	€ 708,443 Total debts 2024: € 708,443 ▲ 68% vs 2023 (€ 422,804) Unfavourable step	€ 567,519 Total debts 2025: € 567,519 ▼ 20% vs 2024 (€ 708,443) Favourable step	▼ 20%
Cash	€ 613,629 Cash 2022: € 613,629 First fiscal year in the series	€ 283,112 Cash 2023: € 283,112 ▼ 54% vs 2022 (€ 613,629) Unfavourable step	€ 823,570 Cash 2024: € 823,570 ▲ 191% vs 2023 (€ 283,112) Favourable step	€ 100,447 Cash 2025: € 100,447 ▼ 88% vs 2024 (€ 823,570) Unfavourable step	▼ 88%
Retained profit	€ 516,433 Retained profit 2022: € 516,433 First fiscal year in the series	€ 790,842 Retained profit 2023: € 790,842 ▲ 53% vs 2022 (€ 516,433) Favourable step	€ 516,433 Retained profit 2024: € 516,433 ▼ 35% vs 2023 (€ 790,842) Unfavourable step	€ 516,433 Retained profit 2025: € 516,433 Unchanged (€ 516,433) Unchanged
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 559,405 Dividend 2024: € 559,405 ▲ € 558,605 vs 2023 (€ 800) Unchanged	€ 308,066 Dividend 2025: € 308,066 ▼ 45% vs 2024 (€ 559,405) Unchanged	▼ 45%
Bank debt	€ 408,236 Bank debt 2022: € 408,236 First fiscal year in the series	€ 297,575 Bank debt 2023: € 297,575 ▼ 27% vs 2022 (€ 408,236) Favourable step	€ 186,410 Bank debt 2024: € 186,410 ▼ 37% vs 2023 (€ 297,575) Favourable step	€ 74,734 Bank debt 2025: € 74,734 ▼ 60% vs 2024 (€ 186,410) Favourable step	▼ 60%
Balance sheet total	€ 1,384,115 Balance sheet total 2022: € 1,384,115 First fiscal year in the series	€ 1,331,848 Balance sheet total 2023: € 1,331,848 ▼ 4% vs 2022 (€ 1,384,115) Unchanged	€ 1,360,353 Balance sheet total 2024: € 1,360,353 ▲ 2% vs 2023 (€ 1,331,848) Unchanged	€ 1,223,240 Balance sheet total 2025: € 1,223,240 ▼ 10% vs 2024 (€ 1,360,353) Unchanged	▼ 10%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	0.7 Employees (FTE) 2023: 0.7 Unchanged (0.7) Unchanged	-	0.6 Employees (FTE) 2025: 0.6 First fiscal year in the series

Key figures of DS - Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DS - Medical?

What happened at DS - Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 308,066 (▲ 8% vs 2024). Source: NBB ↗
Oct 1, 2025 New establishment in Stavelot. KBO
Mar 19, 2021 New establishment in Spa. KBO
Mar 19, 2021 New establishment in Sankt Vith. KBO
Mar 19, 2021 New establishment in Malmedy. KBO
Mar 19, 2021 Start of the company according to the CBE. KBO
2021 Damien SKA became a director. NBB

In short

From € 302,365 profit in 2022 to € 308,066 profit in 2025.

Paid € 446,254 in corporate taxes since 2022.

Best year ever: 2025, with € 308,066 profit.

Paid out € 869,071 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Damien SKA

DS - Medical

La Générale Luxembourgeoise du Crédit

Behind DS - Medical is Damien SKA. Damien SKA is also behind La Générale Luxembourgeoise du Crédit.

Directors

According to the 2025 annual accounts

Damien SKA

Director

Also active at: La Générale Luxembourgeoise du Crédit

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Ster 10 box D

4970 Stavelot

2.315.256.673

Avenue Reine Astrid 178

4900 Spa

Active since 19 March 2021

2.315.256.772

Klosterstrasse 9

4780 Sankt Vith

Active since 19 March 2021

2.315.256.871

Rue Devant les Religieuses 2

4960 Malmedy

Active since 19 March 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

IS - Medical

€ 266,247 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0765.435.017
VAT number: BE 0765.435.017
Registered office: Ster 10 bus D, 4970 Stavelot
Names & denominations: DS - Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 March 2021
Peppol: Active · Active since 12 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

DS - Medical

Warning lights

Financials

What happened to DS - Medical?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions